Nausifar MPS Tablet
Marketer
Infar India Ltd
Salt Composition
Metoclopramide (5mg) + Simethicone (125mg)
Overview Nausifar MPS Tablet
Domperidone and Mosapride combination tablets are prescribed to alleviate vomiting. This medication facilitates gastric emptying, thus preventing nausea and vomiting, and aids in the expulsion of intestinal gas. The tablets should be taken on an empty stomach, following the dosage and duration specified by your physician. Dosage is individualized based on your health and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include dry mouth, diarrhea, fatigue, agitation, and trembling. These are often transient and self-limiting. Report any concerning side effects immediately. Drowsiness is a potential effect; avoid driving or activities requiring concentration until the medication's impact is known. Alcohol consumption should be avoided due to potential additive drowsiness. Consult your physician before use if you are pregnant, intend to become pregnant, are breastfeeding, or have kidney disease to ensure appropriate dosage.
Uses of Nausifar MPS Tablet
Expelling stomach contents
Major Benefits of Nausifar MPS Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Nausifar MPS Tablet on an empty stomach.
Common Side effects of Nausifar MPS Tablet:
- Diarrhea
- Depression
- Weakness
- Sleepiness
- Extrapyramidal symptoms
How to use Nausifar MPS Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nausifar MPS Tablets should be consumed on an empty stomach.
How Nausifar MPS Tablet works:
Nausifar MPS Tablet contains a dual-medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Nausifar MPS Tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Nausifar MPS Tablets is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human trials remains limited.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Nausifar MPS Tablets is potentially risky. Available evidence from humans indicates a possibility of the medication transferring to breast milk, posing a threat to the infant.
DrivingUNSAFE
Driving ability may be impaired by Nausifar MPS Tablet side effects. These side effects can include drowsiness, dizziness, dyskinesia, and dystonia, potentially affecting vision and driving safety.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Nausifar MPS Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Nausifar MPS Tablets in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Nausifar MPS Tablet :
Should you forget a Nausifar MPS Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Nausifar MPS Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
3,018 People bought this recently